Using shRNAs to inhibit LILRB2 expression, they demonstrated that the cultured A549 cancer cells were significantly slower in proliferation and had an increased cell death suggesting that LILRB2 overexpression enhances tumor growth (250). Here, LILRB2 is linked to cancer.